Literature DB >> 27118161

Amputations and mortality in in-hospital treated patients with peripheral artery disease and diabetic foot syndrome.

Nasser M Malyar1, Eva Freisinger2, Matthias Meyborg2, Florian Lüders2, Katrin Gebauer2, Holger Reinecke2, Holger Lawall3.   

Abstract

AIMS: The prevalence of diabetes mellitus (DM) and its associated complications such as peripheral artery disease (PAD) and diabetic foot syndrome (DFS) are increasing worldwide. We aimed to determine the contemporary acute and long-term outcome of patients with PAD and DFS in Germany.
METHODS: Nationwide, anonymized data of 40,335 patients hospitalized for PAD and/or DFS from the years 2009-2011 were analyzed and followed up until 2013. Patients were classified into 3 groups: DFS, PAD+DM and PAD without DM. In-hospital and long-term outcome (1156days, 95% CI 1.151-1.161) regarding major and minor amputation and mortality was assessed. Cumulative amputation-free survival and overall survival rates were calculated using Kaplan-Meier analysis.
RESULTS: The proportion of DFS, PAD+DM and PAD only was 17.3%, 21.5% and 61.2%, respectively. At index-hospitalization, DFS patients had the highest amputation (31.9% vs. 11.1% vs. 6.0%), yet the lowest revascularization rate (18.2% vs. 67.8% vs. 71.6%) compared to patients with PAD only and PAD+DM (P<0.001). Cumulative 4-year survival (57.4%, 60.8% and 70.0%) and amputation-free-survival (45.4%, 74.4% and 86.5%) were lowest for DFS followed by PAD+DM and PAD only (P<0.001).
CONCLUSIONS: Patients with diabetes, particularly those with DFS, have persistent high rates of limb amputation and of mortality in a real-world setting. Our data emphasize the need for further dedicated research to identify and target the underlying causes of the extraordinary poor outcome in this high risk population.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amputation; Diabetes; Diabetic foot syndrome; Mortality; Peripheral artery disease

Mesh:

Year:  2016        PMID: 27118161     DOI: 10.1016/j.jdiacomp.2016.03.033

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  15 in total

1.  [Operative treatment of diabetics with vascular complications : Secondary data analysis of diagnosis-related groups statistics from 2005 to 2014 in Germany].

Authors:  M Olm; A Kühnl; E Knipfer; M Salvermoser; H-H Eckstein; A Zimmermann
Journal:  Chirurg       Date:  2018-07       Impact factor: 0.955

2.  Surgical wound dehiscence complicated by methicillin-resistant Staphylococcus aureus infection in a diabetic patient with femorotibial vascular bypass occlusion.

Authors:  Enrico M Zardi; Nunzio Montelione; Rossella C Vigliotti; Camilla Chello; Domenico M Zardi; Francesco Spinelli; Francesco Stilo
Journal:  Clin Med (Lond)       Date:  2020-01       Impact factor: 2.659

3.  Impact of diabetes on outcome in critical limb ischemia with tissue loss: a large-scaled routine data analysis.

Authors:  Eva Freisinger; Nasser M Malyar; Holger Reinecke; Holger Lawall
Journal:  Cardiovasc Diabetol       Date:  2017-04-04       Impact factor: 9.951

4.  Norwegian trends in numbers of lower extremity revascularisations and amputations including regional trends in endovascular treatments for peripheral arterial disease: a retrospective cross-sectional registry study from 2001 to 2014.

Authors:  Kjersti Wendt; Ronny Kristiansen; Kirsten Krohg-Sørensen; Fredrik Alexander Gregersen; Erik Fosse
Journal:  BMJ Open       Date:  2017-11-14       Impact factor: 2.692

5.  Redefined clinical spectra of diabetic foot syndrome.

Authors:  Nawaf J Shatnawi; Nabil A Al-Zoubi; Hasan Hawamdeh; Yousef S Khader; Abd El-Karim Omari; Muhammad R Khammash
Journal:  Vasc Health Risk Manag       Date:  2018-10-18

6.  Transcutaneous oxygen pressure as a predictor for short-term survival in patients with type 2 diabetes and foot ulcers: a comparison with ankle-brachial index and toe blood pressure.

Authors:  K Fagher; P Katzman; M Löndahl
Journal:  Acta Diabetol       Date:  2018-04-30       Impact factor: 4.280

7.  Unmet medical needs in intermittent Claudication with diabetes and coronary artery disease-A "real-world" analysis on 21 197 PAD patients.

Authors:  Philipp Stalling; Christiane Engelbertz; Florian Lüders; Matthias Meyborg; Katrin Gebauer; Johannes Waltenberger; Holger Reinecke; Eva Freisinger
Journal:  Clin Cardiol       Date:  2019-05-06       Impact factor: 2.882

8.  Current concepts for the evaluation and management of diabetic foot ulcers.

Authors:  Andreas F Mavrogenis; Panayiotis D Megaloikonomos; Thekla Antoniadou; Vasilios G Igoumenou; Georgios N Panagopoulos; Leonidas Dimopoulos; Konstantinos G Moulakakis; George S Sfyroeras; Andreas Lazaris
Journal:  EFORT Open Rev       Date:  2018-09-27

9.  Testing the sympathetic nervous system of the foot has a high predictive value for early amputation in patients with diabetes with a neuroischemic ulcer.

Authors:  Sanne M Schreuder; M Nieuwdorp; Marc J W Koelemay; Shandra Bipat; Jim A Reekers
Journal:  BMJ Open Diabetes Res Care       Date:  2018-11-21

10.  Cost-effectiveness analysis of the human recombinant epidermal growth factor in the management of patients with diabetic foot ulcers.

Authors:  Martin Romero Prada; Carolina Roa; Pamela Alfonso; German Acero; Lina Huérfano; David Vivas-Consuelo
Journal:  Diabet Foot Ankle       Date:  2018-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.